Skip to content
ESE logo
Upcoming calls

This page provides links to a selection of upcoming calls from the Horizon Europe and other European programmes. These have been selected by the ESE Science Committee as calls that are likely to have relevance to endocrinologists.

Horizon Europe Workprogramme 2026 – 2027

European Commission has recently published updates for several parts of Horizon Europe Workprogramme for 2026–2027 - please see below information about calls and deadlines. 

Ten single-stage topics have a complete-proposal deadline of 17 February 2027. For four two-stage topics, that is the first-stage deadline, with the second stage due on 16 September 2027.

Additionally, there will be three one-stage calls with deadline on 16 September 2027.

Please see below list of calls with deadlines:

  • Ten one-stage calls (deadline 17 February 2027) 

HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion

HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change

HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change

HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential

HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses

HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials

HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)

HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals

  • Two stage calls deadlines: 17 February 2027 (first stage), 16 September 2027 (second stage) 

HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases

HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseases

HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics

  • Three one-stage calls have deadlines on 16 September 2027

-            HORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicine

-            HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis

-            HORIZON-HLTH-2027-03-TOOL-08: Towards the next generation of frontier Artificial Intelligence models for healthcare

For more information please consult updates Workprogramme 2026 – 2027 Cluster 1 Health

24–25 November 2026 Cluster Health brokerage event, followed by an information day on 26 November 2026.

More information on brokerage event :  https://www.b2match.com/e/cluster-health-horizon-europe-brokerage-2027

Please note: The event is free of charge,  but registration and profile activation are mandatory to attend the brokerage event.

Cluster 1 Health info day:  https://hadea.ec.europa.eu/events/horizon-europe-info-days-cluster-1-health-2026-11-26_en

Opening date is 10 February 2027 and the final submission deadline is 21 September 2027

HORIZON-MISS-2027-02-CANCER-01:
Leveraging functional genomics to reveal
novel targets for cancer treatment

HORIZON-MISS-2027-02-CANCER-02: Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

HORIZON-MISS-2027-02-CANCER-03:
Phase 1 including first-in-human clinical
trials to test biomarker-guided medicines or
multi-modal treatment interventions for
patients with rare or very rare cancers or
cancer subtypes

HORIZON-MISS-2027-02-CANCER-04: Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research

HORIZON-MISS-2027-02-CANCER-05: Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines

HORIZON-MISS-2027-02-CANCER-06: Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies

For more information please consult Missions Workprogramme 2026 - 2027 (page 88 onwards).

Call

  Opening

Deadline

MSCA Staff Exchanges

15 December 2026

15 April 2027

MSCA Postdoctoral fellowships

  7 April 2027 8 September 2027

MSCA Doctoral Networks

   28 May 2026

24 Nov 2026

 26 May 2027

23 Nov 2027

MSCA COFUND

 8 Dec 2026

6 April 2027

MSCA and Citizens 2027

   To be confirmed

8 June 2027

MSCA Choose Europe for Science 2027

   8 Dec 2026

6 April 2027

Note: MSCA Choose Europe for Science is a pilot initiative under the European Union's Marie Skłodowska-Curie Actions (MSCA) designed to increase the attractiveness of European research careers by reducing job precarity and combating brain drain. Unlike traditional research grants that only offer short-term funding, this scheme selects and funds host organisations based on their ability to offer longer-term employment perspectives and excellent working conditions for researchers.

For more information please consult MSCA Workprogramme 2026 – 2027

Grant Type

Call ID

Opening Date

Closing Deadline

Consolidator Grants

ERC-2027-CoG

24 September 2026

12 January 2027

Synergy Grants

ERC-2027-SyG

17 February 2027

11 May 2027

Advanced Grants

ERC-2027-AdG

27 May 2027

26 August 2027

ERC Plus Grant*

ERC-2027-PLUS

1 June 2027

1 September 2027

*ERC Plus Grant is a new European Research Council initiative providing up to €7 million over 4–7 years for high-risk, transformative, and "breakthrough-oriented" research that exceeds the scope of standard ERC grants. These highly competitive, once-in-a-lifetime, one-time grants are aimed at pioneering projects from researchers of any career stage. 

For more information please consult ERC workprogramme 2027

EIC Pathfinder programs fund early-stage scientific discovery, proof-of-principle validation, and moving lab results toward commercial maturity.

New draft EIC Workprogramme 2027 has been published.

What is new: Pathfinder Open splits into two stages (short & full application) and adds an interview for every above-threshold proposal.

Deadlines for EIC Pathfinder Open are: Stage 1 – 25/02/2027; Stage 2 –16/09/2027

Deadline for EIC Pathfinder Challenges is 29/09/27 and challenges are as following:

  • Breakthroughs in Advanced Materials for Electricity Generation, Storage and Transmission
  • Safe and Controlled Continual Learning in Open World for Reliable AI Agents (CLOWAI)
  • Quantum Energetics

The following topics are under consideration for inclusion in IHI calls 14 and 15, which are planned to be launched in early 2027. These will be the last calls launched under the current programme. 

IHI call 14 draft topic texts

IHI call 15 draft topic texts

The topics are currently under consultation with several stakeholders . They may therefore change considerably between the versions published here and the call launch, and applicants should check the final, approved topic texts once they are published at IHI website.